Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusi Fang

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Oncogene|December 7, 2018
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profilesShannon Grabosch, Mirna Bulatovic, Feitianzhi Zeng, et al.
British Journal of Cancer|January 5, 2023
Mixed invasive ductal lobular carcinoma is clinically and pathologically more similar to invasive lobular than ductal carcinomaAzadeh Nasrazadani, Yujia Li, Yusi Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 ImmunityBrian Orr, Haider Mahdi, Yusi Fang, et al.
Disease Models & Mechanisms|July 11, 2025
Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancerLixin Zhang, Yusi Fang, Ibrahim Uygun, et al.
JAMA Network Open|April 15, 2021
Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast CancerNeil Carleton, Jian Zou, Yusi Fang, et al.
Briefings in Bioinformatics|December 10, 2024
Comprehensive evaluation and practical guideline of gating methods for high-dimensional cytometry data: manual gating, unsupervised clustering, and auto-gatingPeng Liu, Yuchen Pan, Hung-Ching Chang, et al.
Molecular Psychiatry|July 8, 2020
Older molecular brain age in severe mental illnessChien-Wei Lin, Lun-Ching Chang, Tianzhou Ma, et al.
Nature Communications|April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activationZheqi Li, Olivia McGinn, Yang Wu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oncogene|December 7, 2018
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profilesShannon Grabosch, Mirna Bulatovic, Feitianzhi Zeng, et al.
British Journal of Cancer|January 5, 2023
Mixed invasive ductal lobular carcinoma is clinically and pathologically more similar to invasive lobular than ductal carcinomaAzadeh Nasrazadani, Yujia Li, Yusi Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 ImmunityBrian Orr, Haider Mahdi, Yusi Fang, et al.
Disease Models & Mechanisms|July 11, 2025
Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancerLixin Zhang, Yusi Fang, Ibrahim Uygun, et al.
JAMA Network Open|April 15, 2021
Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast CancerNeil Carleton, Jian Zou, Yusi Fang, et al.
Briefings in Bioinformatics|December 10, 2024
Comprehensive evaluation and practical guideline of gating methods for high-dimensional cytometry data: manual gating, unsupervised clustering, and auto-gatingPeng Liu, Yuchen Pan, Hung-Ching Chang, et al.
Molecular Psychiatry|July 8, 2020
Older molecular brain age in severe mental illnessChien-Wei Lin, Lun-Ching Chang, Tianzhou Ma, et al.
Nature Communications|April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activationZheqi Li, Olivia McGinn, Yang Wu, et al.
Pageof 2